Table 1: Clinical and tumoral data and ICH.
|
ICH |
No ICH |
p value |
|
AGE |
< 50y.o |
12 |
22 |
|
> 50y.o |
27 |
48 |
0.73 |
|
GENDER |
Male |
30 |
39 |
|
Female |
9 |
31 |
0.03 |
|
|
Primary |
25 |
50 |
|
TUMOR ORIGIN |
Recurrent or Metastasis |
14 |
20 |
0.25 |
|
Meningioma |
9 |
21 |
|
HISTOPATHOLOGY |
Glioma |
21 |
32 |
|
|
Others |
1 |
14 |
0.22 |
|
Metastasis |
8 |
3 |
|
TUMOR VOLUME NMR |
< 29 ml |
23 |
47 |
0.06 |
≥ 30 ml |
26 |
23 |
||
% TUMOR REMOVAL |
≥ 90% |
31 |
8 |
0.47 |
< 89% |
62 |
8 |
||
|
Seizures |
0 |
1 |
|
POSTOPERATIVE COMPLICATIONS |
Hydrocephalus |
0 |
1 |
|
|
Headache |
2 |
4 |
> 0.1 |
|
Ischemia |
2 |
2 |
|
|
Neurologic |
13 |
14 |
|
|
Deficit |
|
||
|
Sepsis |
5 |
3 |
|
|
Red Cells |
6 |
8 |
|
|
Platelets |
1 |
0 |
|
TRANSFUSION |
Frozen Plasma |
0 |
0 |
|
|
FVII |
0 |
0 |
> 0.1 |
|
Prothrombin |
1 |
0 |
|
|
Complex |
|
||
|
Tranexamic |
4 |
1 |
|
|
Acid |
|
||
ICU STAY |
3,34 ± 2,77 |
1,88 ±1, 31 |
|
< 0.01 |
(mean days) |
||||
DEATH |
Death |
2 |
0 |
0.06 |
No Death |
37 |
70 |